![Stephen Ma](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Ma
Director Financiero/CFO en SCILEX HOLDING COMPANY .
Fortuna: 12 175 $ al 30/04/2024
Perfil
Stephen Ma is currently working as the Secretary, Chief Financial Officer & Senior VP at Scilex Holding Co. He previously worked as the Director-Finance & Operations at Anwita Biosciences, Inc. Mr. Ma has an undergraduate and graduate degree from San Jose State University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
SCILEX HOLDING COMPANY
0.01% | 17/05/2024 | 14 140 ( 0.01% ) | 12 175 $ | 30/04/2024 |
Cargos activos de Stephen Ma
Empresas | Cargo | Inicio |
---|---|---|
SCILEX HOLDING COMPANY | Director Financiero/CFO | 22/09/2023 |
Antiguos cargos conocidos de Stephen Ma.
Empresas | Cargo | Fin |
---|---|---|
Anwita Biosciences, Inc.
![]() Anwita Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company located in the US. Anwita's lead product, exenokine-21, has been accepted by China NMPA and the US FDA to initiate clinical studies. The American company specializes in the discovery and development of optimized immunotherapeutics for cancer and autoimmune diseases. Anwita's core technology integrates structure-guided accukine cytokine evolution and accubody discovery of full spectrum nanobodies and antibodies, enabling the development of fully optimized cytokine fusions with superior therapeutic potential, favorable safety profile, and great development ability. The private company's unique product portfolio includes half-live extended exenokines, immune cell- or tumor cell-targeting mableukines, and bi-functional duoleukins. The company is also developing other cytokine-based therapeutics and antibody drug conjugates for the potential treatment of various cancers. | Director Financiero/CFO | 01/01/2022 |
Formación de Stephen Ma.
San Jose State University | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SCILEX HOLDING COMPANY | Health Technology |
Empresas privadas | 1 |
---|---|
Anwita Biosciences, Inc.
![]() Anwita Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company located in the US. Anwita's lead product, exenokine-21, has been accepted by China NMPA and the US FDA to initiate clinical studies. The American company specializes in the discovery and development of optimized immunotherapeutics for cancer and autoimmune diseases. Anwita's core technology integrates structure-guided accukine cytokine evolution and accubody discovery of full spectrum nanobodies and antibodies, enabling the development of fully optimized cytokine fusions with superior therapeutic potential, favorable safety profile, and great development ability. The private company's unique product portfolio includes half-live extended exenokines, immune cell- or tumor cell-targeting mableukines, and bi-functional duoleukins. The company is also developing other cytokine-based therapeutics and antibody drug conjugates for the potential treatment of various cancers. | Health Technology |
- Bolsa de valores
- Insiders
- Stephen Ma